PHARMACY

A pharmacist handing a prescription to a patient.

NCPA’s comments warn of impact of vertical mergers on independents

NCPA is urging new guidelines to focus on “Frankenstein-like payer/PBM/pharmacies that steer patients and kill off local businesses.”

Surescripts report: Patients want transparent Rx pricing

A new Surescripts survey shows that 94% of respondents who skipped taking a medication because it cost too much would have been willing to take a lower-cost alternative if that were suggested.

Generics companies expand scope, capabilities to fight headwinds

At a time when people expect negative news in the generics industry, many generics firms are managing to thrive.

IQVIA's Long sizes up generics market

Three trends are driving the generics market, according to IQVIA vice president of industry relations Doug Long.

Upsher-Smith, NASPA honor 44 pharmacists

Upsher-Smith and the National Alliance of State Pharmacy Associations are honoring 44 pharmacists for their commitment to patients and their work advancing the pharmacy profession.

Camber intros generic Nexium

Camber's generic Nexium is available in two dosage strengths in 30-, 90- and 1,000-count bottles.

QS/1, Integra plan inaugural iQ Conference

The first-ever iQ Conference will feature a wide range of educational topics, products, and speakers.

Bartell Drugs takes new steps to ensure controlled substance safety

Bartell Drugs is discontinuing sales of promethazine codeine at all pharmacies and is participating in the Washington State secure drug take-back program for the safe disposal of leftover and expired prescriptions.

Geneyork debuts generic Deltasone

Prednisone tablets had a market value of $121 million for 2018, according to IQVIA.

A pharmacist holding a prescription box.

Lupin launches generic Moxeza

Moxifloxacin ophthalmic solution had a market value of approximately $10 million, according to IQVIA December 2019 data.

Upsher-Smith launches 3 generics

Fluvoxamine maleate. haloperidol and clonidine hydrochloride have a combined market value of nearly $102.5 million for the 12 months ending December 2019.

2019 was a very good year for generic drug approvals

In 2019, the FDA gave 1,014 generic drug final and tentative approvals.

Problem solvers: Tech, automation makers aim to enable clinical efforts

Pharmacy technology and automation companies are seeing more industry disruption than ever, and in response, they're ratcheting up their products and services to help pharmacies succeed.

FIP releases coronavirus guidelines for pharmacists

The International Pharmaceutical Federation guidelines will be downloadable in the six official United Nations languages along with other resources on the FIP website.